Exactly Hoffmann. Exactly right, and the UK is not providing Optune either for similar reasons. They doubt that it is worth the cost, 21,000 per month FOREVER. It works supposedly by slowing recurrent tissue from growing, and supposedly doesn't have any impact on normal tissue. What that means is it is necessary forever in case there is any recurrence. It's not an immune therapy and does not utilize the body's own defenses to prevent tumors from growing or to kill remaining tumor tissue, whether after surgery or after recurrence.
I suppose if people want to use it WITH DCVax-L, it might be useful, but the problem is you'd never know when to stop using it, so again, it's $21,000, per month, forever. That is ludicrous if it doesn't really do anything. Great business model. I can see how and why certain interests are so aggressive about it and so defensive as to constantly attack any competing potential treatment that might interfere with that incredible, FOREVER business model. But most of us want to see patients able to get a treatment that will improve their quality of life and extend their lives indefinitely and lastly, that don't cost an arm and a leg.
Optune would cost 252,000 per year, $1,260,000 for five years. And you have to wear it 18 hours per day, every day, forever. Patients who can't can be blamed for their recurrence. Awesome business model. If it didn't work, well, that's the patient's fault.
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
AI
